214 related articles for article (PubMed ID: 23028610)
1. Clinicopathological and prognostic significance of survivin over-expression in patients with esophageal squamous cell carcinoma: a meta-analysis.
Li C; Li Z; Zhu M; Zhao T; Chen L; Ji W; Chen H; Su C
PLoS One; 2012; 7(9):e44764. PubMed ID: 23028610
[TBL] [Abstract][Full Text] [Related]
2. Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma.
Peng H; Yao S; Dong Q; Zhang Y; Gong W; Jia Z; Yan L
Medicine (Baltimore); 2018 Aug; 97(31):e11697. PubMed ID: 30075571
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and predictive significance of SIRT1 and peroxisome proliferator-activated receptor gamma in esophageal squamous cell carcinoma: The correlation with EGFR and Survivin.
Han F; Zhang S; Liang J; Qiu W
Pathol Res Pract; 2018 May; 214(5):686-690. PubMed ID: 29625788
[TBL] [Abstract][Full Text] [Related]
4. Survivin over-expression is correlated with a poor prognosis in esophageal cancer patients.
Xia H; Chen S; Huang H; Ma H
Clin Chim Acta; 2015 Jun; 446():82-5. PubMed ID: 25896962
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and prognostic significance of survivin expression in patients with oral squamous cell carcinoma: evidence from a meta-analysis.
Xie S; Xu H; Shan X; Liu B; Wang K; Cai Z
PLoS One; 2015; 10(2):e0116517. PubMed ID: 25710884
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of HIF-1α and esophageal squamous cell carcinoma (ESCC) risk.
Sun G; Hu W; Lu Y; Wang Y
Pathol Oncol Res; 2013 Oct; 19(4):685-93. PubMed ID: 23658132
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis: clinicopathological and prognostic significance of cyclooxygenase-2 expression on oesophageal squamous cell carcinoma.
Li L; Zhao J; Wu Z; Wang G; Chen G
Aliment Pharmacol Ther; 2009 Sep; 30(6):589-96. PubMed ID: 19549265
[TBL] [Abstract][Full Text] [Related]
10. Clinical correlation of nuclear survivin in esophageal squamous cell carcinoma.
Hui MK; Lai KK; Chan KW; Luk JM; Lee NP; Chung Y; Cheung LC; Srivastava G; Tsao SW; Tang JC; Law S
Med Oncol; 2012 Dec; 29(5):3009-16. PubMed ID: 22528514
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Ku80 suggests poor prognosis of locally advanced esophageal squamous cell carcinoma patients.
Wang S; Wang Z; Liu X; Liu Y; Jia Y
World J Surg; 2015 Jul; 39(7):1773-81. PubMed ID: 25711486
[TBL] [Abstract][Full Text] [Related]
12. Correlation of STAT1 with apoptosis and cell-cycle markers in esophageal squamous cell carcinoma.
Zhang Y; Zhang Y; Yun H; Lai R; Su M
PLoS One; 2014; 9(12):e113928. PubMed ID: 25438156
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and prognostic significance of hypoxia-inducible factor-1α in esophageal squamous cell carcinoma: a meta-analysis.
Ping W; Sun W; Zu Y; Chen W; Fu X
Tumour Biol; 2014 May; 35(5):4401-9. PubMed ID: 24425106
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and prognostic significance of GPX2 protein expression in esophageal squamous cell carcinoma.
Lei Z; Tian D; Zhang C; Zhao S; Su M
BMC Cancer; 2016 Jul; 16():410. PubMed ID: 27388201
[TBL] [Abstract][Full Text] [Related]
15. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
Liu L; Yang Z; Ni W; Xuan Y
Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma].
Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H
Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):361-5. PubMed ID: 24054013
[TBL] [Abstract][Full Text] [Related]
17. Expression of klotho and β-catenin in esophageal squamous cell carcinoma, and their clinicopathological and prognostic significance.
Tang X; Fan Z; Wang Y; Ji G; Wang M; Lin J; Huang S
Dis Esophagus; 2016 Apr; 29(3):207-14. PubMed ID: 25287007
[TBL] [Abstract][Full Text] [Related]
18. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
Zhang Y; Liu YP; Du K; Wang H; Wang XL
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
[TBL] [Abstract][Full Text] [Related]
19. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of PDK1 associates with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro.
Yang Z; Wu Z; Liu T; Han L; Wang C; Yang B; Zheng F
Med Oncol; 2014 Dec; 31(12):337. PubMed ID: 25416048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
